Offered value-based contracts to support access for a new specialty drug
Introduction
Our client is a major biopharmaceutical company entering the chronic pain category with an important new asset with low abuse and addition potential. Recognizing the growing market demand for value-based care, the client asked us to help them develop a strategy and implementation playbook.
The Problem
Our client faced challenges in launching a new brand, needing to understand stakeholder perceptions, current market offerings, and organizational barriers to ensure successful implementation.
Our Solution
- Conducted interviews with a wide variety of stakeholders in the US healthcare market to identify value-based contracting, strengths and weaknesses of current offerings and to test term/structure hypotheses for viability with access stakeholders.
- Identified the organizational challenges the client team would need to overcome to implement VBCs for the new brand.
- Composed a comprehensive catalog of potential VBC targets and in-depth assessment of requirements for success, and stakeholders’ capacity to engage in, alternative agreement types. Forecast evolution in stakeholders’ capacity for VBCs over the next 3-5 years and contract terms the client should offer.
Value Delivered
We developed a comprehensive implementation “playbook” for field teams, providing a structured value-based contracting strategy that equips them with the tools and insights needed to effectively engage stakeholders and drive successful adoption of the new brand.
